RemeGen Co., Ltd. (HKG: 9995)
12.46
0.00 (0.00%)
Sep 9, 2024, 4:08 PM HKT
RemeGen Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Operating Revenue | 1,397 | 1,076 | 767.78 | 1,424 | - | - | Upgrade
|
Other Revenue | 6.82 | 6.82 | 4.33 | - | - | - | Upgrade
|
Revenue | 1,404 | 1,083 | 772.11 | 1,424 | - | - | Upgrade
|
Revenue Growth (YoY) | 66.26% | 40.26% | -45.78% | - | - | - | Upgrade
|
Cost of Revenue | 323.89 | 257.27 | 272.05 | 67.16 | - | - | Upgrade
|
Gross Profit | 1,080 | 825.68 | 500.06 | 1,357 | - | - | Upgrade
|
Selling, General & Admin | 1,106 | 1,079 | 707.01 | 482.81 | 241.8 | 69.06 | Upgrade
|
Research & Development | 1,572 | 1,306 | 982.08 | 710.97 | 465.82 | 352.07 | Upgrade
|
Other Operating Expenses | -9.85 | -22.56 | -13.53 | 41.23 | 3.78 | 3.65 | Upgrade
|
Operating Expenses | 2,676 | 2,371 | 1,686 | 1,235 | 711.46 | 424.77 | Upgrade
|
Operating Income | -1,596 | -1,545 | -1,186 | 121.61 | -711.46 | -424.77 | Upgrade
|
Interest Expense | -48.96 | -23.09 | -6.76 | -5.32 | -29.23 | -43.79 | Upgrade
|
Interest & Investment Income | 35.12 | 35.12 | 73.65 | 43.35 | 1.94 | 0.15 | Upgrade
|
Currency Exchange Gain (Loss) | 1.53 | 1.53 | 13.23 | -25.47 | -32.33 | - | Upgrade
|
Other Non Operating Income (Expenses) | -5.17 | -4.58 | -0.77 | 142.62 | 73.45 | 38.33 | Upgrade
|
EBT Excluding Unusual Items | -1,614 | -1,536 | -1,107 | 276.79 | -697.62 | -430.07 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | -0.22 | - | 0.13 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.79 | -0.79 | -1.02 | -0.31 | -0.21 | -0.34 | Upgrade
|
Other Unusual Items | 25.97 | 25.97 | 108.84 | 0 | 0.01 | - | Upgrade
|
Pretax Income | -1,588 | -1,511 | -998.83 | 276.26 | -697.82 | -430.28 | Upgrade
|
Net Income | -1,588 | -1,511 | -998.83 | 276.26 | -697.82 | -430.28 | Upgrade
|
Net Income to Common | -1,588 | -1,511 | -998.83 | 276.26 | -697.82 | -430.28 | Upgrade
|
Shares Outstanding (Basic) | 539 | 540 | 531 | 487 | 408 | 260 | Upgrade
|
Shares Outstanding (Diluted) | 539 | 540 | 531 | 487 | 408 | 260 | Upgrade
|
Shares Change (YoY) | -1.50% | 1.59% | 9.00% | 19.43% | 56.70% | - | Upgrade
|
EPS (Basic) | -2.95 | -2.80 | -1.88 | 0.57 | -1.71 | -1.65 | Upgrade
|
EPS (Diluted) | -2.95 | -2.80 | -1.88 | 0.57 | -1.71 | -1.65 | Upgrade
|
Free Cash Flow | - | -2,356 | -2,013 | -351.44 | -1,104 | -347.96 | Upgrade
|
Free Cash Flow Per Share | - | -4.36 | -3.79 | -0.72 | -2.70 | -1.34 | Upgrade
|
Gross Margin | 76.92% | 76.24% | 64.77% | 95.28% | - | - | Upgrade
|
Operating Margin | -113.71% | -142.70% | -153.61% | 8.54% | - | - | Upgrade
|
Profit Margin | -113.17% | -139.55% | -129.36% | 19.40% | - | - | Upgrade
|
Free Cash Flow Margin | - | -217.51% | -260.74% | -24.68% | - | - | Upgrade
|
EBITDA | -1,417 | -1,373 | -1,062 | 187.84 | -661.56 | -383.76 | Upgrade
|
EBITDA Margin | -100.94% | -126.82% | -137.54% | 13.19% | - | - | Upgrade
|
D&A For EBITDA | 179.27 | 172.02 | 124.03 | 66.24 | 49.89 | 41 | Upgrade
|
EBIT | -1,596 | -1,545 | -1,186 | 121.61 | -711.46 | -424.77 | Upgrade
|
EBIT Margin | -113.71% | -142.70% | -153.61% | 8.54% | - | - | Upgrade
|
Revenue as Reported | 1,083 | 1,083 | 772.11 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.